Lv6
2620 积分 2022-07-12 加入
Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma
1个月前
已完结
Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial
7个月前
已完结
Efficacy and Safety of Ofatumumab Treatment for Anti‐NMDA Receptor Autoimmune Encephalitis (OFF‐AE): A Prospective, Multicenter Cohort Study
7个月前
已完结
Correction: Iptacopan: First Approval
7个月前
已完结
Efficacy of olopatadine ophthalmic solution 0.2% in reducing signs and symptoms of allergic conjunctivitis
8个月前
已完结
Efficacy of Alcaftadine 0.25% (AGN-229666) for Once-daily Prevention of Cedar-Pollen Allergic Conjunctivitis: A Phase 3 Randomized Study
8个月前
已完结
Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO
8个月前
已关闭
Treatment of Allergic Conjunctivitis: Results of a 1-Month, Single-Masked Randomized Study
9个月前
已完结
Ivarmacitinib, a selective Janus kinase 1 inhibitor, in patients with moderate-to-severe active rheumatoid arthritis and inadequate response to conventional synthetic DMARDs: results from a phase III randomised clinical trial
9个月前
已完结
JACQLQ subjective symptom questionnaire score and clinical test results for patients with allergic conjunctival disease
9个月前
已完结
皖公网安备34019202002308
